Viewing Study NCT03340506


Ignite Creation Date: 2025-12-26 @ 5:23 PM
Ignite Modification Date: 2025-12-31 @ 11:52 PM
Study NCT ID: NCT03340506
Status: RECRUITING
Last Update Posted: 2025-11-10
First Post: 2017-11-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dabrafenib and/or Trametinib Rollover Study
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module